Site-directed antibodies to low-voltage-activated calcium channel CaV3.3 (alpha1I) subunit also target neural cell adhesion molecule-180. | Neuroscience;145(3): 981-96, 2007 Mar 30. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Site-directed antibodies to low-voltage-activated calcium channel CaV3.3 (alpha1I) subunit also target neural cell adhesion molecule-180.

Chen, Y; Sharp, A H; Hata, K; Yunker, A M R; Polo-Parada, L; Landmesser, L T; McEnery, M W.

Affiliation

Chen Y; Department of General Medical Sciences, Case Western Reserve University, School of Medicine, 10900 Euclid Avenue, Cleveland, OH 44106, USA.

Neuroscience ; 145(3): 981-96, 2007 Mar 30.

Article in En | MEDLINE | ID: mdl-17317015

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Membrane Transport Proteins / Calcium Channel Blockers / Calcium Channels, T-Type / Antibodies Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Neuroscience Year: 2007 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Membrane Transport Proteins / Calcium Channel Blockers / Calcium Channels, T-Type / Antibodies Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Neuroscience Year: 2007 Document type: Article Affiliation country: